VELARU GALACTIC EXHIBIT PACK — GXP / FDA 21 CFR PART 11 PHARMA
Jurisdiction: Global / Multi-jurisdiction (global)
Modality: Text / Chat
Program: Velaru Mandate Registry — GxP / FDA 21 CFR Part 11 Pharma (galactic_gxp)
Product ID: gxp:global:bundle:text
Vertical: gxp
Generated: 2026-08-11T00:23:09.150356Z
Authority: Global External Validation — GxP Electronic Records Integrity Pack
Deadline: FDA Part 11 + EU GMP Annex 11
Velaru verify: https://velaru.onrender.com/verify

EXHIBIT A — AI INVENTORY
[]

EXHIBIT B — GOVERNANCE FRAMEWORK
{
  "framework": "Velaru Mandate Registry \u2014 GxP / FDA 21 CFR Part 11 Pharma",
  "exhibit_authority": "Global External Validation \u2014 GxP Electronic Records Integrity Pack",
  "regulatory_frameworks": [
    "FDA 21 CFR Part 11",
    "FDA 21 CFR Part 211 GMP",
    "ICH E6 GCP",
    "ICH Q10 Pharmaceutical Quality System",
    "EU GMP Annex 11",
    "WHO GMP guidelines",
    "FDA 483 observation risk",
    "ISO 42001",
    "NIST AI RMF 1.0",
    "OECD AI Principles"
  ],
  "standards_alignment": [
    "POSS-2",
    "DRP-1",
    "TCB",
    "FRE 707 pre-compliance",
    "ISO 42001"
  ],
  "human_oversight": "release manufacturing batch",
  "third_party_verification": "https://velaru.onrender.com/verify (operator-independent)",
  "data_lineage": "Hash-chained Ed25519 receipts; optional RFC3161 + external anchor",
  "mirror_trap": "QA releases batch on AI recommendation without hash-chained record \u2014 batch recall insurance void. \u00b7 Multinationals built for one jurisdiction fail exams in another \u2014 one receipt architecture, many filing packs.",
  "chain_integrity": {
    "depth": 39,
    "invariant_holds": true
  }
}

EXHIBIT D — DATA INPUTS & VALIDATION
{
  "data_validation_method": "Cryptographic receipt per AI decision; public verify without trusting deployer, vendor, or Velaru operator",
  "bias_testing_proxy": "Asymmetry score from live chain signals",
  "model_change_control": "Policy lock registry \u2014 criteria hash frozen pre-dispute",
  "logging_retention": "90-day pre-dispute window minimum; permanent verify permalinks",
  "external_validator": "Nisaba LLC / Velaru",
  "validator_independence": "Client-side Ed25519 verify; BYOK tri-receipt optional",
  "headline_stat": "Delete audit trail before inspection = automatic consent decree pattern",
  "global_leaders_addressed": [
    "FDA",
    "Merck",
    "Lonza",
    "Waters Corporation",
    "ISPE",
    "ISO",
    "NIST",
    "OECD"
  ]
}

MIRROR TRAP (regulatory insight)
QA releases batch on AI recommendation without hash-chained record — batch recall insurance void. · Multinationals built for one jurisdiction fail exams in another — one receipt architecture, many filing packs.

NERVE CARDS — WHY GLOBAL LEADERS CARE
[
  {
    "title": "Deviation reports",
    "body": "AI flags GMP deviation \u2014 without receipt, QA cannot prove when they knew.",
    "source": "vertical"
  },
  {
    "title": "Annex 11 EU",
    "body": "European GMP requires same integrity \u2014 global pharma needs one primitive.",
    "source": "vertical"
  },
  {
    "title": "Recall insurance",
    "body": "Insurers deny recall claims when electronic records integrity violated.",
    "source": "vertical"
  },
  {
    "title": "[Global / Multi-jurisdiction] Jurisdiction shopping ends",
    "body": "Regulators share examination findings via IAIS, IOSCO, Basel \u2014 governance gap in one market triggers another.",
    "source": "jurisdiction"
  },
  {
    "title": "[Global / Multi-jurisdiction] Vendor contract forum",
    "body": "AI vendor chooses Delaware law \u2014 deployer owns EU, UK, and US state fines simultaneously.",
    "source": "jurisdiction"
  },
  {
    "title": "[Text / Chat] Modality hook",
    "body": "Baseline \u2014 all frameworks apply to text decisions.",
    "source": "modality"
  }
]

BOOK SUMMARY: {
  "total_insureds": 0,
  "compliant": 0,
  "grace_period": 0,
  "non_compliant": 0,
  "expired": 0,
  "not_enrolled": 0,
  "compliant_pct": 0.0
}

TAM / EXPOSURE: Every GMP facility globally · Part 11 is law today
INSURANCE LINES: Product recall, Pharma E&O

DISCLAIMER: External validation evidence pack — not legal advice, not filed rate approval.